Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts.
Zeidan AM, Platzbecker U, Garcia-Manero G, Sekeres MA, Fenaux P, DeZern AE, Greenberg PL, Savona MR, Jurcic JG, Verma AK, Mufti GJ, Buckstein R, Santini V, Shetty JK, Ito R, Zhang J, Zhang G, Ha X, Backstrom JT, Komrokji RS.
Zeidan AM, et al. Among authors: mufti gj.
Blood. 2022 Nov 17;140(20):2170-2174. doi: 10.1182/blood.2022016171.
Blood. 2022.
PMID: 35797468
Free PMC article.